Tower Research Capital LLC (Trc) Vectiv Bio Holding Ag Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 14, 2023	SELL	$8.29 - $16.97 $762 - $1,561	-92 Reduced 33.21%	185 $3,000
Q1 2023 May 09, 2023	BUY	$7.34 - $9.15 $2,033 - $2,534	277 New	277 $2,000
Q4 2021 Feb 14, 2022	SELL	$2.83 - $7.26 $2,897 - $7,434	-1,024 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.7 - $11.54 $4,542 - $7,824	678 Added 195.95%	1,024 $8,000
Q2 2021 Aug 16, 2021	BUY	$11.66 - $24.23 $4,034 - $8,383	346 New	346 $4,000

Others Institutions Holding VECT

# of Institutions

1

Shares Held

510K

Call Options Held

0

Put Options Held

0

Regency Capital Management Inc.\De

510K
Shares

$0
0.0% of portfolio

About VectivBio Holding AG

Ticker VECT
Exchange NASDAQ
Description
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...

More about VECT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.